IL2 and neoplasm: Instead, we found that in this fully immunocompetent tumor model, improved CAR T cell-mediated tumor control was only observed with the autocrine configuration of the synthetic IL-2 circuit – i.e. the cytotoxic receptor (CAR) and the synNotch→IL-2 circuit must be encapsulated within the same cell (Fig 2C, S7B).